Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
CHLORHEXIDINE GLUCONATE
Schering Plough Limited
QD08AC02
0.425 %w/v
Antiseptics
Bovine
1999-10-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) VPA: 10277/053/001 Case No: 7006162 The Irish Medicines Board in exercise of the powers conferred on it by Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: SCHERING PLOUGH LIMITED SHIRE PARK, WELWYN GARDEN CITY, HERTFORDSHIRE AL7 1TW, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: HIBITEX 0.425% W/V TEAT DIP/SPRAY The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said Schedule. The authorisation, unless previously revoked, shall continue in force from 30/09/2009. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: From this date of effect, this authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 05/06/2010_ _CRN 7006162_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Hibitex 0.425% w/v Teat Dip/Spray 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Teat dip/spray solution. A dark red solution. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dairy Cows. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES As an aid in the control of mastitis in lactating dairy cows and in the prevention and healing of chapp Läs hela dokumentet